Trial Information
Integrated Whole-Genome Analysis of Hematologic Disorders Using High-Throughput Sequencing and Array Technologies
Inclusion Criteria:
1. 18 years of age or older
2. Patient meets the clinical and/or pathologic criteria for the hematologic disorder
being examined.
3. Patient is willing to provide a skin biopsy and five 10 mL tubes of peripheral blood.
Exclusion Criteria:
1. Less than 18 years of age
2. Patient is not willing to provide a skin biopsy and five 10 mL tubes of peripheral
blood.
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Principal Investigator
James L Zehnder
Investigator Role:
Principal Investigator
Investigator Affiliation:
Stanford University
Authority:
United States: Institutional Review Board
Study ID:
HEM0013
NCT ID:
NCT01108159
Start Date:
September 2009
Completion Date:
Related Keywords:
- Hematologic Diseases
- Hematologic Diseases
Name | Location |
Stanford University School of Medicine |
Stanford, California 94305-5317 |